Uncharacterized Protein, Uncharacterized
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Related structures:
AlphaFold database: E9AH74
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 137 | 139 | PF00675 | 0.457 |
CLV_NRD_NRD_1 | 151 | 153 | PF00675 | 0.390 |
CLV_NRD_NRD_1 | 174 | 176 | PF00675 | 0.462 |
CLV_NRD_NRD_1 | 198 | 200 | PF00675 | 0.467 |
CLV_NRD_NRD_1 | 201 | 203 | PF00675 | 0.477 |
CLV_NRD_NRD_1 | 206 | 208 | PF00675 | 0.472 |
CLV_PCSK_FUR_1 | 178 | 182 | PF00082 | 0.520 |
CLV_PCSK_FUR_1 | 199 | 203 | PF00082 | 0.480 |
CLV_PCSK_KEX2_1 | 137 | 139 | PF00082 | 0.420 |
CLV_PCSK_KEX2_1 | 180 | 182 | PF00082 | 0.526 |
CLV_PCSK_KEX2_1 | 200 | 202 | PF00082 | 0.522 |
CLV_PCSK_KEX2_1 | 205 | 207 | PF00082 | 0.528 |
CLV_PCSK_KEX2_1 | 48 | 50 | PF00082 | 0.495 |
CLV_PCSK_PC1ET2_1 | 180 | 182 | PF00082 | 0.526 |
CLV_PCSK_PC1ET2_1 | 200 | 202 | PF00082 | 0.522 |
CLV_PCSK_PC1ET2_1 | 48 | 50 | PF00082 | 0.465 |
CLV_PCSK_PC7_1 | 201 | 207 | PF00082 | 0.521 |
CLV_PCSK_SKI1_1 | 129 | 133 | PF00082 | 0.475 |
CLV_PCSK_SKI1_1 | 238 | 242 | PF00082 | 0.493 |
CLV_PCSK_SKI1_1 | 9 | 13 | PF00082 | 0.532 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.543 |
DEG_SPOP_SBC_1 | 33 | 37 | PF00917 | 0.459 |
DOC_MAPK_gen_1 | 180 | 189 | PF00069 | 0.484 |
DOC_PP4_FxxP_1 | 87 | 90 | PF00568 | 0.368 |
DOC_USP7_MATH_1 | 216 | 220 | PF00917 | 0.601 |
DOC_USP7_UBL2_3 | 176 | 180 | PF12436 | 0.465 |
DOC_WW_Pin1_4 | 16 | 21 | PF00397 | 0.545 |
LIG_14-3-3_CanoR_1 | 152 | 158 | PF00244 | 0.481 |
LIG_14-3-3_CanoR_1 | 265 | 271 | PF00244 | 0.615 |
LIG_14-3-3_CanoR_1 | 3 | 11 | PF00244 | 0.544 |
LIG_Actin_WH2_2 | 225 | 240 | PF00022 | 0.516 |
LIG_Actin_WH2_2 | 95 | 111 | PF00022 | 0.393 |
LIG_BRCT_BRCA1_1 | 46 | 50 | PF00533 | 0.553 |
LIG_deltaCOP1_diTrp_1 | 222 | 228 | PF00928 | 0.490 |
LIG_deltaCOP1_diTrp_1 | 79 | 87 | PF00928 | 0.393 |
LIG_FHA_1 | 227 | 233 | PF00498 | 0.501 |
LIG_FHA_1 | 39 | 45 | PF00498 | 0.560 |
LIG_FHA_2 | 35 | 41 | PF00498 | 0.432 |
LIG_LIR_Apic_2 | 84 | 90 | PF02991 | 0.378 |
LIG_LIR_Gen_1 | 140 | 147 | PF02991 | 0.449 |
LIG_LIR_Gen_1 | 222 | 233 | PF02991 | 0.473 |
LIG_LIR_Gen_1 | 47 | 57 | PF02991 | 0.470 |
LIG_LIR_Gen_1 | 79 | 90 | PF02991 | 0.345 |
LIG_LIR_Nem_3 | 140 | 146 | PF02991 | 0.445 |
LIG_LIR_Nem_3 | 222 | 228 | PF02991 | 0.471 |
LIG_LIR_Nem_3 | 47 | 53 | PF02991 | 0.494 |
LIG_LIR_Nem_3 | 56 | 62 | PF02991 | 0.382 |
LIG_LIR_Nem_3 | 79 | 85 | PF02991 | 0.360 |
LIG_SH2_GRB2like | 101 | 104 | PF00017 | 0.357 |
LIG_SH2_STAT5 | 171 | 174 | PF00017 | 0.515 |
LIG_SH2_STAT5 | 31 | 34 | PF00017 | 0.468 |
LIG_SH2_STAT5 | 59 | 62 | PF00017 | 0.439 |
LIG_SH2_STAT5 | 82 | 85 | PF00017 | 0.348 |
LIG_TRAF2_1 | 212 | 215 | PF00917 | 0.475 |
LIG_TRFH_1 | 87 | 91 | PF08558 | 0.374 |
MOD_CK1_1 | 21 | 27 | PF00069 | 0.410 |
MOD_CK1_1 | 266 | 272 | PF00069 | 0.609 |
MOD_CK2_1 | 216 | 222 | PF00069 | 0.495 |
MOD_CK2_1 | 34 | 40 | PF00069 | 0.417 |
MOD_GlcNHglycan | 12 | 15 | PF01048 | 0.638 |
MOD_GlcNHglycan | 218 | 221 | PF01048 | 0.535 |
MOD_GlcNHglycan | 55 | 58 | PF01048 | 0.502 |
MOD_GSK3_1 | 1 | 8 | PF00069 | 0.577 |
MOD_GSK3_1 | 113 | 120 | PF00069 | 0.493 |
MOD_GSK3_1 | 12 | 19 | PF00069 | 0.529 |
MOD_GSK3_1 | 216 | 223 | PF00069 | 0.523 |
MOD_GSK3_1 | 251 | 258 | PF00069 | 0.557 |
MOD_GSK3_1 | 34 | 41 | PF00069 | 0.486 |
MOD_GSK3_1 | 85 | 92 | PF00069 | 0.433 |
MOD_N-GLC_1 | 113 | 118 | PF02516 | 0.469 |
MOD_N-GLC_1 | 226 | 231 | PF02516 | 0.484 |
MOD_N-GLC_1 | 53 | 58 | PF02516 | 0.465 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.549 |
MOD_NEK2_1 | 10 | 15 | PF00069 | 0.554 |
MOD_NEK2_1 | 158 | 163 | PF00069 | 0.453 |
MOD_NEK2_1 | 44 | 49 | PF00069 | 0.509 |
MOD_NEK2_1 | 53 | 58 | PF00069 | 0.430 |
MOD_NEK2_1 | 85 | 90 | PF00069 | 0.400 |
MOD_NEK2_2 | 263 | 268 | PF00069 | 0.716 |
MOD_PKA_2 | 151 | 157 | PF00069 | 0.484 |
MOD_PKA_2 | 174 | 180 | PF00069 | 0.464 |
MOD_PKA_2 | 2 | 8 | PF00069 | 0.619 |
MOD_PKA_2 | 242 | 248 | PF00069 | 0.532 |
MOD_PKA_2 | 251 | 257 | PF00069 | 0.543 |
MOD_PKA_2 | 44 | 50 | PF00069 | 0.364 |
MOD_Plk_1 | 185 | 191 | PF00069 | 0.473 |
MOD_Plk_1 | 83 | 89 | PF00069 | 0.468 |
MOD_Plk_4 | 158 | 164 | PF00069 | 0.447 |
MOD_ProDKin_1 | 16 | 22 | PF00069 | 0.537 |
MOD_SUMO_rev_2 | 70 | 75 | PF00179 | 0.483 |
TRG_ENDOCYTIC_2 | 59 | 62 | PF00928 | 0.325 |
TRG_ENDOCYTIC_2 | 82 | 85 | PF00928 | 0.350 |
TRG_ER_diArg_1 | 199 | 202 | PF00400 | 0.481 |
TRG_ER_diArg_1 | 205 | 207 | PF00400 | 0.481 |
TRG_NLS_MonoExtN_4 | 199 | 204 | PF00514 | 0.495 |
TRG_Pf-PMV_PEXEL_1 | 129 | 133 | PF00026 | 0.507 |
TRG_Pf-PMV_PEXEL_1 | 156 | 160 | PF00026 | 0.474 |
TRG_Pf-PMV_PEXEL_1 | 235 | 239 | PF00026 | 0.478 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P7U3 | Leptomonas seymouri | 85% | 100% |
A0A0S4JQ00 | Bodo saltans | 52% | 100% |
A0A1X0NW91 | Trypanosomatidae | 78% | 100% |
A0A3S7WYJ0 | Leishmania donovani | 100% | 100% |
A4HDM7 | Leishmania braziliensis | 94% | 100% |
C9ZWD8 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 73% | 100% |
E9AX12 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 96% | 100% |
Q4QAG4 | Leishmania major | 96% | 100% |
V5BK26 | Trypanosoma cruzi | 75% | 99% |